Upgrade to SI Premium - Free Trial

Puma Biotechnology (PBYI) PT Raised to $164 at Citi, 'Buy The Dip'

November 10, 2017 4:14 AM
Citi raised its price target on Puma Biotechnology (NASDAQ: PBYI) to $164.00 (from $156.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments

Next Articles